 
            IndraLab
Statements
                                      reach
                                
                                  
                                
                                
          
          
                                  "We demonstrate here that ESD increases the nuclear localization of p53 by JAB1, and it is vitally important to find a new factor to regulate p53 and inhibit tumor growth.Here, we found that a novel factor esterase D (ESD) reduced the interaction between JAB1 and p53 to suppress cancer cell growth."
          
                              
          
                               
                            
                                      reach
                                
                                  
                                
                                
          
          
                                  "When Jab1 was co-expressed with S149D and T150E, their nuclear export pattern was similar to wild-type p53, and was inhibited by curcumin, suggesting that S149 and T150 on p53 are dispensable for Jab1 mediated p53 translocation (XREF_FIG and XREF_SUPPLEMENTARY, panels 1-12 and 21-32)."
          
                              
          
                               
                            
                                      reach
                                
                                  
                                
                                
          
          
                                  "In this study, we found that activating ESD by FPD5 significantly inhibited the interaction between JAB1 and p53, which would reduce the effect of nuclear exportation of p53 by JAB1, which increased the nuclear localization of p53 and provided a good condition for p53 to regulate other genes’ expression in the nucleus."
          
                              
          
                               
                            
                                      reach
                                
                                  
                                
                                
          
          
                                  "The nuclear and cytoplasmic co-localization between COPS5 and p53 suggests a mechanism of COPS5 and p53 interaction and relocalization of p53 from the nucleus to the cytoplasm, and treatment of MG132, a potent proteasome inhibitor, significantly inhibited proteasome dependent protein degradation of p53 and enhanced its levels in cytoplasm, which indicated the degradation of p53 induced by COPS5."